CEO Per Walday. Picture: DnBNOR, Stig Fiksdal
Press release, PCI Biotech, Oslo, Norway, 7 September 2011
At a ceremony at the Norwegian bank DnB NOR in Oslo on 6 September 2011, PCI Biotech was awarded both the prestigious DnB NOR’s Innovation prize 2011 and the Peoples award.
The Innovation prize of NOK 1,000.000 was handed over by Rune Bjerke, CEO of DnB NOR and the Peoples award of NOK 100,000 was handed over by jury member and member of parliament, Per Kristian Foss (H).
-We are very happy and proud for receiving these awards. This is a great recognition and a huge motivation for all of us, says Per Walday, CEO of PCI Biotech.
A total of 716 companies competed in the contest and 10 companies from all around Norway were selected to participate in the final. The Innovation prize was selected by a jury, and jury members were; Berit Kjøll (chairman), Shazad Rana, Rune Bjerke, Siv Jensen, Kjell A. Storeide, Per Kristian Foss and Paul Chaffey. The Peoples award was decided through internet votes and SMS.
PCI Biotech is a member of Oslo Cancer Cluster and one of the speakers at European Cancer Cluster Partnering, ECCP2011 in Toulouse, France next week.
Related articles:The Tumours Fell off before our eyes, PCI shines new light on localised cancer treatment.